Patent: 5,707,648
✉ Email this page to a colleague
▶ Start for $100
Remove trial restrictions
Summary for Patent: 5,707,648
| Title: | Transparent liquid for encapsulated drug delivery |
| Abstract: | There is provided a stable transparent multi-component composition useful for the delivery of water soluble active agents to animals. The compositions are formulated with a mixture of an oil phase, an aqueous phase, and a surfactant system, along with the active agent to be delivered to the animal. The compositions are specially formulated to be compatible with capsules such as gelatin and starch capsules. The aqueous phase of the compositions contains a substantial amount of polyethylene glycol and can optionally also contain a plasticizer. Preferred active agents are proteinaceous materials. |
| Inventor(s): | Yiv; Seang H. (Wilmington, DE) |
| Assignee: | LDS Technologies, Inc. (Boothwyn, PA) |
| Application Number: | 08/406,935 |
| Patent Claims: | see list of patent claims |
Details for Patent 5,707,648
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Microbix Biosystems Inc. | KINLYTIC | urokinase | For Injection | 021846 | 01/16/1978 | ⤷ Sign Up | 2015-01-13 |
| Smith & Nephew, Inc. | SANTYL | collagenase | Ointment | 101995 | 06/04/1965 | ⤷ Sign Up | 2015-01-13 |
| Emergent Biosolutions Canada Inc. | BAT | botulism antitoxin heptavalent (a, b, c, d, e, f, g) - (equine) | Solution | 125462 | 03/22/2013 | ⤷ Sign Up | 2015-01-13 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
